Buderer Drug Co. granted Imprimis Pharmaceuticals rights to undisclosed IP a right of first refusal to license additional IP

Buderer Drug Co.

U.S. / Other

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Imprimis Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced